Search Results for "Dr. Wetzler on CDX-1401 in Combination with Decitabine in Patients with MDS"

Dr. Wetzler on CDX-1401 in Combination with Decitabine in Patients with MDS

Effect of BMT status on decitabine plus ipilimumab in R/R MDS/AML

Novel therapies for older patients with AML and MDS

Venetoclax with decitabine for high-risk AML and MDS

Dr. Patricia L. Kropf on Decitabine and Arsenic Trioxide in AML and MDS

Dr. Wetzler on the Mechanism of Action of Omacetaxine

Onvansertib with cytarabine or decitabine for R/R AML

Vosaroxin and Decitabine in Newly Diagnosed Older Patients with AML and High Risk MDS

CRUSH!!MDS - Phase 2 Randomized Study of Lower Doses of Decitabine Clinical Study - crushmds.org

Management of Patients with MDS and Cytopenias

Promising results in MDS for ASTX727, an oral decitabine and cytidine deaminase inhibitor agent

Making MDS Treatment Decisions Easier